DRUG DELIVERY DEVICE
1 Assignment
0 Petitions
Accused Products
Abstract
The present disclosure presents systems, devices and methods for injection of drugs, substances and/or chemicals to a patient and for improving their effectiveness once they are injected are disclosed. Additional treatment can be applied to a tissue region on the patient into which a drug (e.g., insulin) is injected, to expose the tissue region to various forms of energy or a substance to improve the drug'"'"'s pharmacokinetic and/or pharmacodynamic profile.
125 Citations
127 Claims
-
1-80. -80. (canceled)
-
81. An apparatus for delivering therapeutic fluid to a patient at an injection site, comprising:
-
a fluid injection device having a housing, wherein the housing contains; an injector for injecting the therapeutic fluid to the injection site; and a reservoir for containing the therapeutic fluid; a treatment element coupled to the fluid injection device and configured to apply treatment to the injection site; wherein the treatment element is further configured to improve pharmacokinetic and/or pharmacodynamic property of the therapeutic fluid either a short time before, during and/or following injection of the therapeutic fluid into the patient. - View Dependent Claims (82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113)
-
-
114. A method for delivering a therapeutic fluid to an injection site on a patient using a fluid delivery device having a fluid injection device having a housing, wherein the housing includes an injector for injecting the therapeutic fluid to the injection site and a reservoir for containing the therapeutic fluid, and a treatment element coupled to the fluid injection device and configured to apply treatment to the injection site, comprising the steps of:
-
using the fluid injection device, injecting the therapeutic fluid at the injection site; using the treatment element, applying a treatment to at least one of the injection site and adjacent the injection site; and improving pharmacokinetic and/or pharmacodynamic property of the therapeutic fluid upon application of the treatment. - View Dependent Claims (115, 116, 117, 118, 119, 120, 121, 122, 123, 125, 126, 127)
-
-
124. The method according to claim 124, wherein the therapeutic fluid is insulin.
Specification